Skip to main content

Table 3 Proportion and percentage of subjects taking cardiovascular-related medication types at the last clinical assessment prior to death.

From: Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease

Medication Class

Alzheimer's

Control

Anti-angina

0 (0%)

1 (4.8%)

Anti-arrhythmia

2 (7.4%)

2 (9.5%)

Anti-platelet

13 (48.1%)

7 (33.3%)

Anti-diabetic

2 (7.4%)

5 (23.8%)

Anti-hypertensive

7 (25.9%)*

15 (71.4%)

Lipid-lowering

5 (18.5%)

6 (28.6%)

  1. * p < 0.05, Fisher's exact test
  2. There were no significant differences between groups except for the proportion taking anti-hypertensive agents. Data was available for 27 AD subjects and 21 control subjects.
Back to article page

BMC Geriatrics

ISSN: 1471-2318

Contact us